LYEL
Lyell Immunopharma, Inc.NASDAQHealthcare$21.21+2.26%ClosedMarket Cap: $494.3M
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
9
Sales
7
Buy/Sell Ratio
1.29
Total Bought
$0.00
Total Sold
$7.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Mon Mar 16 | Shah Smital | officer: Chief Fin. and Bus. Officer | Sell | 140,000 | $25.50 | 140,000 |
| Mon Mar 16 | Shah Smital | Sell | 0 | $0.00 | 0 | |
| Mon Mar 09 | ARCH Venture Partners IX, LLC | 10 percent owner | Buy | 488,090 | $25.61 | 1,426,528 |
| Mon Mar 09 | ARCH Venture Fund XIII, L.P. | 10 percent owner | Buy | 488,090 | $25.61 | 1,426,528 |
| Thu Feb 12 | Seely Lynn | director, officer: President and CEO | Sell | 7,455 | $23.39 | 74,266 |
| Thu Feb 12 | Hill Stephen J. | officer: Chief Operating Officer | Sell | 1,236 | $23.39 | 17,795 |
| Thu Feb 12 | Lee Gary K. | officer: Chief Scientific Officer | Sell | 1,671 | $23.39 | 16,938 |
| Wed Feb 11 | Hill Stephen J. | officer: Chief Operating Officer | Sell | 65,000 | $23.71 | 65,000 |
| Wed Feb 11 | Hill Stephen J. | officer: Chief Operating Officer | Sell | 4,000 | $0.00 | 19,140 |
| Wed Feb 11 | Hill Stephen J. | officer: Chief Operating Officer | Sell | 109 | $23.12 | 19,031 |